TaiMed Biologics Inc. (TPEX:4147)
49.40
+1.35 (2.81%)
Apr 29, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 13.50 billion as of April 29, 2026. Its market cap has decreased by -43.84% in one year.
Market Cap
13.50B
Enterprise Value
12.22B
Revenue
611.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.40
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 13.50B, an increase of 423.02%. That is a compound annual growth rate of 11.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 13.80B |
| Locus Cell | 12.20B |
| Ever Supreme Bio Technology | 11.61B |
| Polaris Group | 15.01B |
| Medigen Vaccine Biologics | 15.78B |
| Tanvex BioPharma | 10.62B |
| AP Biosciences | 16.73B |
| CHO Pharma | 9.48B |